Early research (Phase 1)Study completedNCT01374113What this trial is testingSafinamide Renal Impairment TrialWho this might be right forRenal Impairment Newron Pharmaceuticals SPA 24
Not applicableUnknownNCT04256720What this trial is testingThe Multi-Ethnic Lifestyle StudyWho this might be right forDiabetes MellitusChronic Kidney DiseasesCardiovascular Diseases+7 more University of Leicester 9,500
Early research (Phase 1)Study completedNCT03107663What this trial is testing⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaWho this might be right forPositron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more ImaginAb, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01361113What this trial is testingNeoadjuvant Pazopanib in Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma UNC Lineberger Comprehensive Cancer Center 21
Not applicableLooking for participantsNCT04442516What this trial is testingCisplatin Induced Kidney ToxicityWho this might be right forAcute Kidney InjuryCancer The Hospital for Sick Children 600
Not applicableActive Not RecruitingNCT01582204What this trial is testingEvaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cancer Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01064310What this trial is testingPatient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney CancerWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 169
Testing effectiveness (Phase 2)Study completedNCT00664326What this trial is testingA Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCCWho this might be right forCarcinoma, Renal Cell Bayer 49
Early research (Phase 1)Study completedNCT01169584What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsWho this might be right forNeuroblastomaRhabdomyosarcomaLymphoma+2 more Jennerex Biotherapeutics 6
Not applicableActive Not RecruitingNCT05863052What this trial is testingAnalyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationWho this might be right forImmune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more University of Oklahoma 72
Very early researchStudy completedNCT05728515What this trial is testingA Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 3
Not applicableEnded earlyNCT01598038What this trial is testingRelation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Centre Francois Baclesse 41
Testing effectiveness (Phase 2)Study completedNCT00019955What this trial is testingRadiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)Who this might be right forKidney Cancer National Cancer Institute (NCI)
Post-approval studies (Phase 4)Ended earlyNCT03821376What this trial is testingCorrelation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)Who this might be right forRenal Malignant Tumor Indiana University 12
Testing effectiveness (Phase 2)Study completedNCT03015740What this trial is testingSitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00021021What this trial is testingRPI.4610 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Ribozyome
Not applicableStudy completedNCT07436416What this trial is testingCirculating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney CancerWho this might be right forRenal Cell Carcinoma Institute of Oncology Ljubljana 91
Not applicableStudy completedNCT04189835What this trial is testingEVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant RecipientsWho this might be right forEBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more University of Aarhus 509
Not applicableStudy completedNCT04402749What this trial is testingThe Incidence of Pulmonary Embolism During NephrectomyWho this might be right forPulmonary EmbolismRenal Cell CarcinomaNephrectomy Mahidol University 416
Not applicableStudy completedNCT06119347What this trial is testingAcute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint InhibitorsWho this might be right forAKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs First Affiliated Hospital of Wenzhou Medical University 1,581